Browse Arkansas Code titles and sections
38 U.S.C. § 7309A — Office of Patient Advocacy
Federal law — U.S. Code and appendices · legal_authorities
Page 1169
TITLE 38—VETERANS’ BENEFITS
§ 7309A
1 See References in Text note below.
‘‘(F) The term ‘veteran’ means an individual who
served in the Armed Forces, including an individual
who served in a reserve component of the Armed
Forces, and who was discharged or released there-
from, regardless of the conditions of such discharge
or release.
‘‘(g) DEFINITION OF VET CENTER.—In this section, the
term ‘Vet Center’ has the meaning given that term in
section 1712A(h) of title 38, United States Code.’’
§ 7309A. Office of Patient Advocacy
(a) ESTABLISHMENT.—There is established in
the Department within the Office of the Under
Secretary for Health an office to be known as
the ‘‘Office of Patient Advocacy’’ (in this sec-
tion referred to as the ‘‘Office’’).
(b) HEAD.—(1) The Director of the Office of Pa-
tient Advocacy shall be the head of the Office.
(2) The Director of the Office of Patient Advo-
cacy shall be appointed by the Under Secretary
for Health from among individuals qualified to
perform the duties of the position and shall re-
port directly to the Under Secretary for Health.
(c) FUNCTION.—(1) The function of the Office is
to carry out the Patient Advocacy Program of
the Department.
(2) In carrying out the Patient Advocacy Pro-
gram of the Department, the Director shall en-
sure that patient advocates of the Department—
(A) advocate on behalf of veterans with re-
spect to health care received and sought by
veterans under the laws administered by the
Secretary;
(B) carry out the responsibilities specified in
subsection (d); and
(C) receive training in patient advocacy.
(3) Beginning not later than 18 months after
the date of the enactment of this paragraph, the
Director shall establish an information tech-
nology system that will allow a v
Source: Supplied 2024 U.S. Code historical extraction · 38 U.S.C. § 7309A
Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: 89192227c16133f398706f229ac17bac8109b67b9383d8e2325dbeae7619ee7a. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:usc2024-94d039fb60e7f12f40d5dc9e
Source file: Laws/federal/codes/united-states-code-2024/title-38/section-7309a-office-of-patient-advocacy--b4e830022f.md
Pages: Not recorded – Not recorded
Passage SHA-256: 37e81f440ce824559a1d63d5926b453876ffc1daa90469b984c1f0f53e67c80e
Source location: USCODE-2024-title38-partV-chap73-subchapI-sec7309A.pdf
Stored source content
Page 1169
TITLE 38—VETERANS’ BENEFITS
§ 7309A
1 See References in Text note below.
‘‘(F) The term ‘veteran’ means an individual who
served in the Armed Forces, including an individual
who served in a reserve component of the Armed
Forces, and who was discharged or released there-
from, regardless of the conditions of such discharge
or release.
‘‘(g) DEFINITION OF VET CENTER.—In this section, the
term ‘Vet Center’ has the meaning given that term in
section 1712A(h) of title 38, United States Code.’’
§ 7309A. Office of Patient Advocacy
(a) ESTABLISHMENT.—There is established in
the Department within the Office of the Under
Secretary for Health an office to be known as
the ‘‘Office of Patient Advocacy’’ (in this sec-
tion referred to as the ‘‘Office’’).
(b) HEAD.—(1) The Director of the Office of Pa-
tient Advocacy shall be the head of the Office.
(2) The Director of the Office of Patient Advo-
cacy shall be appointed by the Under Secretary
for Health from among individuals qualified to
perform the duties of the position and shall re-
port directly to the Under Secretary for Health.
(c) FUNCTION.—(1) The function of the Office is
to carry out the Patient Advocacy Program of
the Department.
(2) In carrying out the Patient Advocacy Pro-
gram of the Department, the Director shall en-
sure that patient advocates of the Department—
(A) advocate on behalf of veterans with re-
spect to health care received and sought by
veterans under the laws administered by the
Secretary;
(B) carry out the responsibilities specified in
subsection (d); and
(C) receive training in patient advocacy.
(3) Beginning not later than 18 months after
the date of the enactment of this paragraph, the
Director shall establish an information tech-
nology system that will allow a veteran (or the
designated representative of a veteran) to elec-
tronically—
(A) file a complaint that will be received by
the appropriate patient advocate; and
(B) at any time view the status of the com-
plaint, including interim and final actions
that have been taken to address the com-
plaint.
(d) PATIENT ADVOCACY RESPONSIBILITIES.—The
responsibilities of each patient advocate at a
medical facility of the Department are the fol-
lowing:
(1) To resolve complaints by veterans with
respect to health care furnished under the
laws administered by the Secretary that can-
not be resolved at the point of service or at a
higher level easily accessible to the veteran.
(2) To present at various meetings and to
various committees the issues experienced by
veterans in receiving such health care at such
medical facility.
(3) To express to veterans their rights and
responsibilities as patients in receiving such
health care.
(4) To manage the Patient Advocate Track-
ing System of the Department at such medical
facility.
(5) To compile data at such medical facility
of complaints made by veterans with respect
to the receipt of such health care at such med-
ical facility and the satisfaction of veterans
with such health care at such medical facility
to determine whether there are trends in such
data.
(6) To ensure that a process is in place for
the distribution of the data compiled under
paragraph (5) to appropriate leaders, commit-
tees, services, and staff of the Department.
(7) To identify, not less frequently than
quarterly, opportunities for improvements in
the furnishing of such health care to veterans
at such medical facility based on complaints
by veterans.
(8) To ensure that any significant complaint
by a veteran with respect to such health care
is brought to the attention of appropriate staff
of the Department to trigger an assessment of
whether there needs to be a further analysis of
the problem at the facility-wide level.
(9) To support any patient advocacy pro-
grams carried out by the Department.
(10) To ensure that all appeals and final deci-
sions with respect to the receipt of such health
care are entered into the Patient Advocate
Tracking System of the Department.
(11) To understand all laws, directives, and
other rules with respect to the rights and re-
sponsibilities of veterans in receiving such
health care, including the appeals processes
available to veterans.
(12) To ensure that veterans receiving men-
tal health care, or the surrogate decision-mak-
ers for such veterans, are aware of the rights
of veterans to seek representation from sys-
tems established under section 103 of the Pro-
tection and Advocacy for Mentally Ill Individ-
uals Act of 1986 1 (42 U.S.C. 10803) to protect
and advocate the rights of individuals with
mental illness and to investigate incidents of
abuse and neglect of such individuals.
(13) To fulfill requirements established by
the Secretary with respect to the inspection of
controlled substances.
(14) To document potentially threatening be-
havior and report such behavior to appropriate
authorities.
(e) TRAINING.—In providing training to patient
advocates under subsection (c)(2)(C), the Direc-
tor shall ensure that such training is consistent
throughout the Department.
(f) CONTROLLED SUBSTANCE DEFINED.—In this
section, the term ‘‘controlled substance’’ has
the meaning given that term in section 102 of
the Controlled Substances Act (21 U.S.C. 802).
(Added Pub. L. 114–198, title IX, § 924(a), July 22,
2016, 130 Stat. 767; amended Pub. L. 117–175, § 2,
Sept. 16, 2022, 136 Stat. 2107.)
Editorial Notes
REFERENCES IN TEXT
The date of the enactment of this paragraph, referred
to in subsec. (c)(3), is the date of enactment of Pub. L.
117–175, which was approved Sept. 16, 2022.
The Protection and Advocacy for Mentally Ill Indi-
viduals Act of 1986, referred to in subsec. (d)(12), was re-
named the Protection and Advocacy for Individuals
with Mental Illness Act by Pub. L. 106–310, div. B, title
XXXII, § 3206(a), Oct. 17, 2000, 114 Stat. 1193.
AMENDMENTS
2022—Subsec. (c)(3). Pub. L. 117–175 added par. (3).
Page 1170
TITLE 38—VETERANS’ BENEFITS
§ 7310
Statutory Notes and Related Subsidiaries
DATE FULLY OPERATIONAL
Pub. L. 114–198, title IX, § 924(c), July 22, 2016, 130
Stat. 769, provided that: ‘‘The Secretary of Veterans Af-
fairs shall ensure that the Office of Patient Advocacy
established under section 7309A of title 38, United
States Code, as added by subsection (a), is fully oper-
ational not later than the date that is one year after
the date of the enactment of this Act [July 22, 2016].’’
§ 7310. Office of Women’s Health
(a) ESTABLISHMENT.—(1) The Under Secretary
for Health shall establish and operate in the
Veterans Health Administration the Office of
Women’s Health (in this section referred to as
the ‘‘Office’’).
(2) The Office shall be located at the Central
Office of the Department of Veterans Affairs.
(3)(A) The head of the Office is the Chief Offi-
cer of Women’s Health (in this section referred
to as the ‘‘Chief Officer’’).
(B) The Chief Officer shall report to the Under
Secretary for Health.
(4) The Under Secretary for Health shall pro-
vide the Office with such staff and other support
as may be necessary for the Office to carry out
effectively the functions of the Office under this
section.
(5) The Under Secretary for Health may reor-
ganize existing offices within the Veterans
Health Administration as of the date of the en-
actment of this section in order to avoid dupli-
cation with the functions of the Office.
(b) FUNCTIONS.—The functions of the Office in-
clude the following:
(1) To provide a central office for monitoring
and encouraging the activities of the Veterans
Health Administration with respect to the
provision, evaluation, and improvement of
health care services provided to women vet-
erans by the Department.
(2) To develop and implement standards of
care for the provision of health care for
women veterans by the Department.
(3) To monitor and identify deficiencies in
standards of care for the provision of health
care for women veterans by the Department,
to provide technical assistance to medical fa-
cilities of the Department to address and rem-
edy deficiencies, and to perform oversight of
implementation of such standards of care.
(4) To monitor and identify deficiencies in
standards of care for the provision of health
care for women veterans provided through the
community pursuant to this title and to pro-
vide recommendations to the appropriate of-
fice to address and remedy any deficiencies.
(5) To oversee distribution of resources and
information related to health programming
for women veterans under this title.
(6) To promote the expansion and improve-
ment of clinical, research, and educational ac-
tivities of the Veterans Health Administration
with respect to the health care of women vet-
erans.
(7) To provide, as part of the annual budg-
eting process, recommendations with respect
to the amounts to be requested for furnishing
hospital care and medical services to women
veterans pursuant to chapter 17 of this title,
including, at a minimum, recommendations
that ensure that such amounts either reflect
or exceed the proportion of veterans enrolled
in the system of patient enrollment of the De-
partment established and operated under sec-
tion 1705(a) of this title who are women.
(8) To provide recommendations to the
Under Secretary for Health with respect to
modifying the Veterans Equitable Resource
Allocation system, or successor system, to en-
sure that resource allocations under such sys-
tem, or successor system, reflect the health
care needs of women veterans.
(9) To carry out such other duties as the
Under Secretary for Health may require.
(c) RECOMMENDATIONS.—(1) If the Under Sec-
retary for Health determines not to implement
any recommendation made by the Chief Officer
with respect to the allocation of resources to ad-
dress the health care needs of women veterans,
the Secretary shall notify the appropriate con-
gressional committees of such determination by
not later than 30 days after the date on which
the Under Secretary for Health receives the rec-
ommendation.
(2) Each notification under paragraph (1) relat-
ing to a determination with respect to a rec-
ommendation shall include the following:
(A) The reasoning of the Under Secretary for
Health in making the determination.
(B) An alternative, if one is selected, to the
recommendation that the Under Secretary for
Health will carry out to fulfill the health care
needs of women veterans.
(d) STANDARDS OF CARE.—For purposes of car-
rying out the functions of the Office under this
section, the standards of care for the provision
of health care for women veterans from the De-
partment shall include, at a minimum, the fol-
lowing:
(1) A requirement for—
(A) at least one designated women’s health
primary care provider at each medical cen-
ter of the Department whose duties include,
to the extent practicable, providing training
to other health care providers of the Depart-
ment with respect to the needs of women
veterans; and
(B) at least one designated women’s health
primary care provider at each community-
based outpatient clinic of the Department
who may serve women patients as a percent-
age of the total duties of the provider.
(2) Other requirements as determined by the
Under Secretary for Health.
(e) OUTREACH.—The Chief Officer shall ensure
that—
(1) not less frequently than biannually, each
medical facility of the Department holds a
public forum for women veterans that occurs
outside of regular business hours; and
(2) not less frequently than quarterly, each
medical facility of the Department convenes a
focus group of women veterans that includes a
discussion of harassment occurring at such fa-
cility.
(f) DEFINITIONS.—In this section:
(1) The term ‘‘appropriate congressional
committees’’ has the meaning given that term
in section 7310A(h) of this title.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
As used in this subchapter:
(1) The term “addict” means any individual who habitually uses any narcotic drug so as to endanger the public morals, health, safety, or welfare, or who is so far addicted to the use of narcotic drugs as to have lost the power of self-control with reference to his addiction.
(2) The term “administer” refers to the direct application of a controlled substance to the body of a patient or research subject by—
(A) a practitioner (or, in his presence, by his authorized agent), or
(B) the patient or research subject at the direction and in the presence of the practitioner,
whether such application be by injection, inhalation, ingestion, or any other means.
(3) The term “agent” means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser; except that such term does not include a common or contract carrier, public warehouseman, or employee of the carrier or warehouseman, when acting in the usual and lawful course of the carrier’s or warehouseman’s business.
(4) The term “Drug Enforcement Administration” means the Drug Enforcement Administration in the Department of Justice.
(5) The term “control” means to add a drug or other substance, or immediate precursor, to a schedule under part B of this subchapter, whether by transfer from another schedule or otherwise.
(6) The term “controlled substance” means a drug or other substance, or immediate precursor, included in schedule I, II, III, IV, or V of part B of this subchapter. The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are defined or used in subtitle E of the Internal Revenue Code of 1986.
(7) The term “counterfeit substance” means a controlled substance which, or the container or labelin
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 802
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 802. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 782
TITLE 21—FOOD AND DRUGS
§ 801a
ing it into counterfeit opioid pills. Because fentanyl is
lethal in even miniscule doses, this is an extremely
deadly tactic, as it too often causes users to ingest a
fatal amount unknowingly.
SEC. 2. Agency Action. The Secretary of Health and
Human Services shall, consistent with section 319 of
the Public Health Service Act, 42 U.S.C. 247d, consider
declaring that the drug demand and opioid crisis de-
scribed in section 1 of this memorandum constitutes a
Public Health Emergency. Additionally, the heads of
executive departments and agencies, as appropriate and
consistent with law, shall exercise all appropriate
emergency authorities, as well as other relevant au-
thorities, to reduce the number of deaths and minimize
the devastation the drug demand and opioid crisis in-
flicts upon American communities.
SEC. 3. General Provisions. (a) Nothing in this memo-
randum shall be construed to impair or otherwise af-
fect:
(i) the authority granted by law to an executive de-
partment or agency, or the head thereof; or
(ii) the functions of the Director of the Office of Man-
agement and Budget relating to budgetary, administra-
tive, or legislative proposals.
(b) This memorandum shall be implemented con-
sistent with applicable law and subject to the avail-
ability of appropriations.
(c) This memorandum is not intended to, and does
not, create any right or benefit, substantive or proce-
dural, enforceable at law or in equity by any party
against the United States, its departments, agencies, or
entities, its officers, employees, or agents, or any other
person.
(d) The Secretary of Health and Human Services is
hereby authorized and directed to publish this memo-
randum in the Federal Register.
DONALD J. TRUMP.
§ 801a
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 802
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 802. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Establishment.—** There is established in the Department within the Office of the Under Secretary for Health an office to be known as the “Office of Patient Advocacy” (in this section referred to as the “Office”).
**(b) Head.—**
(1) The Director of the Office of Patient Advocacy shall be the head of the Office.
(2) The Director of the Office of Patient Advocacy shall be appointed by the Under Secretary for Health from among individuals qualified to perform the duties of the position and shall report directly to the Under Secretary for Health.
**(c) Function.—**
(1) The function of the Office is to carry out the Patient Advocacy Program of the Department.
(2) In carrying out the Patient Advocacy Program of the Department, the Director shall ensure that patient advocates of the Department—
(A) advocate on behalf of veterans with respect to health care received and sought by veterans under the laws administered by the Secretary;
(B) carry out the responsibilities specified in subsection (d); and
(C) receive training in patient advocacy.
(3) Beginning not later than 18 months after the date of the enactment of this paragraph, the Director shall establish an information technology system that will allow a veteran (or the designated representative of a veteran) to electronically—
(A) file a complaint that will be received by the appropriate patient advocate; and
(B) at any time view the status of the complaint, including interim and final actions that have been taken to address the complaint.
**(d) Patient Advocacy Responsibilities.—** The responsibilities of each patient advocate at a medical facility of the Department are the following:
(1) To resolve complaints by veterans with respect to health care furnished under the laws administered by th
Source: Supplied U.S. Code snapshot — release unconfirmed · 38 U.S.C. § 7309A
Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.
Federal law — U.S. Code and appendices · legal_authorities
The Secretary shall make allotments under this subchapter to eligible systems to establish and administer systems—
(1) which meet the requirements of [section 10805 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section10805&num=0&edition=prelim); and
(2) which are designed to—
(A) protect and advocate the rights of individuals with mental illness; and
(B) investigate incidents of abuse and neglect of individuals with mental illness if the incidents are reported to the system or if there is probable cause to believe that the incidents occurred.
Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 10803
Stored review status: release_metadata_unconfirmed. The source passage cites 42 U.S.C. § 10803. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 8084
TITLE 42—THE PUBLIC HEALTH AND WELFARE
§ 10803
1 So in original. The comma probably should not appear.
2 See References in Text note below.
106–402, Oct. 30, 2000, 114 Stat. 1677. Subtitle C of the Act
probably means subtitle C of title I of the Act, which
is classified generally to part C (§ 15041 et seq.) of sub-
chapter I of chapter 144 of this title. For complete clas-
sification of this Act to the Code, see Short Title note
set out under section 15001 of this title and Tables.
The Developmental Disabilities Assistance and Bill of
Rights Act, referred to in par. (8), is title I of Pub. L.
88–164, as added by Pub. L. 98–527, § 2, Oct. 19, 1984, 98
Stat. 2662, which was repealed by Pub. L. 106–402, title
IV, § 401(a), Oct. 30, 2000, 114 Stat. 1737. Part C of the Act
was classified generally to subchapter III (§ 6041 et seq.)
of chapter 75 of this title. Provisions similar to former
part C of the Act are contained in subtitle C of title I
of the Developmental Disabilities Assistance and Bill
of Rights Act of 2000, Pub. L. 106–402, which is classified
generally to part C (§ 15041 et seq.) of subchapter I of
chapter 144 of this title.
AMENDMENTS
2000—Par. (2). Pub. L. 106–402 substituted ‘‘subtitle C
of the Developmental Disabilities Assistance and Bill
of Rights Act of 2000’’ for ‘‘part C of the Developmental
Disabilities Assistance and Bill of Rights Act’’.
Par. (4). Pub. L. 106–310, § 3206(b)(1)(A), inserted
‘‘, except as provided in section 10804(d) of this title,’’
after ‘‘means’’ in introductory provisions.
Par. (4)(B). Pub. L. 106–310, § 3206(b)(1)(B), designated
existing provisions as cl. (i), redesignated former cls. (i)
to (iii) as subcls. (I) to (III), respectively, of cl. (i), and
added cl. (ii).
Par. (8). Pub. L. 106–3
Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 10803
Stored review status: historical_2024_not_currentness_verified. The source passage cites 42 U.S.C. § 10803. This identifies an authority to review, not proof of applicability.